Cell-free DNA (cfDNA) is present in various body fluids and originates mostly from blood
cells. In specific conditions, circulating cfDNA might be derived from tumours, donor organs …

The present study aimed to investigate the effects of sevoflurane post-conditioning in a rat
brain cerebral ischemia-reperfusion (I/R) model and examine its possible mechanism. Rats …

There is currently no proposed stroke biomarker with consistent application in clinical
practice. A number of studies have examined cell-free DNA (cfDNA), which circulates in …

Ischemic stroke is the most common type of stroke and is caused by vascular closure.
Chlorogenic acid is a polyphenolic compound that is present in various plants. It is used as a …

A number of studies have demonstrated that resveratrol (Res), a natural polyphenol
compound found in plants, shows potent neuroprotective, anti-inflammatory and antioxidant …

Objective: The objective of this work was to assess the ability of peripheral blood cell-free
DNA (cfDNA) levels to identify ischaemic stroke early in the acute phase of care, as well as …

Cerebral ischemia is a severe, acute condition, normally caused by cerebrovascular
disease, and results in high rates of disability, and death. Phagoptosis is a newly recognized …

Stroke is a major cause of global morbidity and mortality. Middle cerebral artery occlusion
(MCAO) has historically been the most common animal model of simulating ischemic stroke …

Post-stroke depression (PSD) is a common and serious complication following stroke. Both
stroke and depression have independently been associated with pathologically elevated …

Background Even though more than 600 stroke treatments have been shown effective in
preclinical studies, clinically proven treatment alternatives for cerebral infarction remain …